Tulsi needs your support to make it into the next debates. Even a dollar helps. Go here
H/T Marijuana Moment
Sen. Kamala Harris (D-CA) dismissed criticism of her record as a prosecutor who jailed marijuana offenders and later joked about her own cannabis consumption on Wednesday, refusing to respond to an attack that Rep. Tulsi Gabbard (D-HI) laid during the Democratic presidential debate.
During a post-debate interview on CNN, host Anderson Cooper played a clip of Gabbard saying she’s “deeply concerned about this record,” referring to Harris’s time as California’s attorney general.
“There are too many examples to cite, but she put over 1,500 people in jail for marijuana violations and then laughed about it when she was asked if she ever smoked marijuana,” Gabbard said, drawing applause.
“Taken as a whole, we concluded that medical cannabis does not consist of a single therapeutic agent but rather a heterogeneous array of treatments,” the researchers wrote. “We propose that the fate of specific cancer cells following cannabis extract application is dependent upon the synergistic effects of its phytocannabinoid composition, concentration applied, along with the cell specific characteristics (e.g. cannabimimetic receptor expression).”
“using whole cannabis extracts is more effective in inducing cancer cell death than applying pure [THC] on the studied cells lines.”
Santander, Spain: Subjects with a history of cannabis use are less likely than abstainers to develop non-alcoholic fatty liver disease (NAFLD), according to longitudinal data published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry.
A team of Spanish investigators assessed the relationship between cannabis use and liver steatosis over a three-year period. They determined that those subjects “who reported continuing cannabis use were at lower risk for developing NAFLD.”
They concluded: “Our results suggest that using cannabis could have a protective effect on liver steatosis. The beneficial effect of cannabis at the level of the development of steatosis seems to be secondary to its modulation effect on weight gain and the reduced development of obesity. … These results are in line with previous studies in the general population, in which cannabis showed significantly lower NAFLD prevalence compared to non-users.”
For more information, contact Paul Armentano, NORML Deputy Director. Full text of the study, “Cannabis consumption and non-alcoholic fatty liver disease: A three years longitudinal study in first episode non-affective psychosis patients,” appears in Progress in Neuro-Psychopharmacology and Biological Psychiatry.